Introduction. - Miller-Fisher syndrome is defined by the triad: ophtha
lmoplegia, ataxia and areflexia. This rare entity is generally regarde
d as a variant of the Guillain-Barre syndrome, although neurophysiolog
ical patterns differ. In the acute phase of the disease, sera of affec
ted patients contain high titers of antigangliosid anti-Gg1b, which is
a specific marker. Recurrences are exceptional. Exegese. - We report
the case of a man with three recurrences of Miller-Fisher syndrome wit
hin 16 years. Anti-GQ1b antibody titers were elevated during an episod
, decreasing but nor completely and vanishing 2 years later. Intraveno
us human immunoglobulin treatment probably accelerated improvement at
the two last episods. Conclusions. - Some experimental and immunohisto
chemical data from the literature argue for a probable direct pathogen
ic role of antibodies against GQ1b gangliosid in this syndrome. This s
hould be a rationale for the use of immunomodulating treatments. (C) 1
998, Elsevier, Paris.